Brief: Karyopharm Therapeutics Q1 Net Income USD -37.362 Million
May 08 (Reuters) - Karyopharm Therapeutics Q1 product revenue USD 26.006 million. * Q1 operating expenses USD 66.885 million * Q1 operating income USD -33.759 million * outlook FY revenue USD 140-160 million